Lytton, Laurence W. 13D and 13G filings for HTG Molecular Diagnostics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 3:33 pm Sale | 2022-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | Lytton, Laurence W. | 0 0.000% | -6,260,292 (Position Closed) | Filing |
| 2022-02-15 2:16 pm Purchase | 2021-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | Lytton, Laurence W. | 6,260,292 6.800% | 447,348 (+7.70%) | Filing |
| 2021-02-16 11:37 am Purchase | 2020-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM | Lytton, Laurence W. | 5,812,944 9.990% | 5,812,944 (New Position) | Filing |